FASEB J. Probiotics Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Opgenorth, T. J.
Right arrow Articles by Shiosaki, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Opgenorth, T. J.
Right arrow Articles by Shiosaki, K.

The FASEB Journal, Vol 6, 2653-2659, Copyright © 1992 by The Federation of American Societies for Experimental Biology


REVIEWS

Endothelin-converting enzymes

TJ Opgenorth, JR Wu-Wong and K Shiosaki
Pharmaceutical Products Division, Abbott Laboratories, Illinois 60064.

The putative endothelin-converting enzyme (ECE) has been the focus of intense research, both within academia and the pharmaceutical industry. Interest in ECE stems mainly from the hypothesis that development of inhibitors of ECE will provide an effective means of preventing production of endothelin in circumstances where it may play a pathogenic role. Both an aspartic and a metalloprotease have been identified that have characteristics of this putative enzyme. Evidence suggests that the metalloprotease, which is inhibited by phosphoramidon, may be the physiologically relevant converting enzyme. However, it remains to be demonstrated conclusively that any inhibitor of an ECE activity directly alters endogenous endothelin production and/or the pathogenesis of a disease condition in which endothelin is thought to play a primary role.


This article has been cited by other articles:


Home page
J. Exp. Biol.Home page
K. A. Hyndman and D. H. Evans
Endothelin and endothelin converting enzyme-1 in the fish gill: evolutionary and physiological perspectives
J. Exp. Biol., December 15, 2007; 210(24): 4286 - 4297.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
M J Grimshaw
Endothelins and hypoxia-inducible factor in cancer
Endocr. Relat. Cancer, June 1, 2007; 14(2): 233 - 244.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
C. Y. Shin, Y. P. Lee, T. S. Lee, H. D. Je, D. S. Kim, and U. D. Sohn
The Signal Transduction of Endothelin-1-Induced Circular Smooth Muscle Cell Contraction in Cat Esophagus
J. Pharmacol. Exp. Ther., September 1, 2002; 302(3): 924 - 934.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
M. F. Wright, B. Sayre, E. Keith Inskeep, and J. A. Flores
Prostaglandin F2{alpha} Regulation of the Bovine Corpus Luteum Endothelin System During the Early and Midluteal Phase
Biol Reprod, December 1, 2001; 65(6): 1710 - 1717.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. Ihling, T. Szombathy, B. Bohrmann, M. Brockhaus, H. E. Schaefer, and B. M. Loeffler
Coexpression of Endothelin-Converting Enzyme-1 and Endothelin-1 in Different Stages of Human Atherosclerosis
Circulation, August 21, 2001; 104(8): 864 - 869.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. A. Grantham, J. A. Schirger, P. W. Wennberg, S. Sandberg, D. M. Heublein, T. Subkowski, and J. C. Burnett Jr
Modulation of Functionally Active Endothelin-Converting Enzyme by Chronic Neutral Endopeptidase Inhibition in Experimental Atherosclerosis
Circulation, April 25, 2000; 101(16): 1976 - 1981.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. Hoffman, Z. A. Abassi, S. Brodsky, R. Ramadan, and J. Winaver
Mechanisms of Big Endothelin-1-Induced Diuresis and Natriuresis : Role of ETB Receptors
Hypertension, March 1, 2000; 35(3): 732 - 739.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
C. Fernandez-Patron, M. W. Radomski, and S. T. Davidge
Vascular Matrix Metalloproteinase-2 Cleaves Big Endothelin-1 Yielding a Novel Vasoconstrictor
Circ. Res., November 12, 1999; 85(10): 906 - 911.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
K. Barnes and A. J Turner
Endothelin converting enzyme is located on {alpha}-actin filaments in smooth muscle cells
Cardiovasc Res, June 1, 1999; 42(3): 814 - 822.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
A. Tripiciano, C. Peluso, A. R. Morena, F. Palombi, M. Stefanini, E. Ziparo, M. Yanagisawa, and A. Filippini
Cyclic Expression of Endothelin-converting Enzyme-1 Mediates the Functional Regulation of Seminiferous Tubule Contraction
J. Cell Biol., May 31, 1999; 145(5): 1027 - 1038.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
P. Korth, R. M. Bohle, P. Corvol, and F. Pinet
Cellular Distribution of Endothelin-converting Enzyme-1 in Human Tissues
J. Histochem. Cytochem., April 1, 1999; 47(4): 447 - 462.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Kobayashi, T. Miyauchi, S. Sakai, M. Kobayashi, I. Yamaguchi, K. Goto, and Y. Sugishita
Expression of endothelin-1, ETA and ETB receptors, and ECE and distribution of endothelin-1 in failing rat heart
Am J Physiol Heart Circ Physiol, April 1, 1999; 276(4): H1197 - H1206.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
Y. NAKAYAMA, H. NONOGUCHI, S. KIYAMA, M. IKEBE, Y. TASHIMA, K. SHIMADA, K. TANZAWA, and K. TOMITA
Intranephron Distribution and Regulation of Endothelin-Converting Enzyme-1 in Cyclosporin A-Induced Acute Renal Failure in Rats
J. Am. Soc. Nephrol., March 1, 1999; 10(3): 562 - 571.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Maeda, T. Miyauchi, S. Sakai, T. Kobayashi, M. Iemitsu, K. Goto, Y. Sugishita, and M. Matsuda
Prolonged exercise causes an increase in endothelin-1 production in the heart in rats
Am J Physiol Heart Circ Physiol, December 1, 1998; 275(6): H2105 - H2112.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
T. J Rabelink, E. S.G Stroes, K.P. Bouter, and P. Morrison
Endothelin blockers and renal protection: a new strategy to prevent end-organ damage in cardiovascular disease?
Cardiovasc Res, September 1, 1998; 39(3): 543 - 549.
[Full Text] [PDF]


Home page
Circ. Res.Home page
F. D. Russell, J. N. Skepper, and A. P. Davenport
Human Endothelial Cell Storage Granules : A Novel Intracellular Site for Isoforms of the Endothelin-Converting Enzyme
Circ. Res., August 10, 1998; 83(3): 314 - 321.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
D. S. McKenna, P. Samuels, P. D. Zimmerman, and D. A. Kniss
Interleukin-I{alpha}, Epidermal Growth Factor, and Transforming Growth Factor-{beta} Exhibit Differential Kinetics on Endothelin-I Synthesis in Amnion Cells
Reproductive Sciences, January 1, 1998; 5(1): 25 - 30.
[Abstract] [PDF]


Home page
HypertensionHome page
K. Barnes, C. Brown, and A. J. Turner
Endothelin-Converting Enzyme: Ultrastructural Localization and Its Recycling From the Cell Surface
Hypertension, January 1, 1998; 31(1): 3 - 9.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Peri, G. Fantoni, S. Granchi, G. B. Vannelli, T. Barni, S. Amerini, C. Pupilli, G. Barbagli, G. Forti, M. Serio, et al.
Gene Expression of Endothelin-1, Endothelin-Converting Enzyme-1, and Endothelin Receptors in Human Epididymis
J. Clin. Endocrinol. Metab., November 1, 1997; 82(11): 3797 - 3806.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
C. Pupilli, P. Romagnani, L. Lasagni, F. Bellini, N. Misciglia, N. Emoto, M. Yanagisawa, M. Rizzo, M. Mannelli, and M. Serio
Localization of endothelin-converting enzyme-1 in human kidney
Am J Physiol Renal Physiol, November 1, 1997; 273(5): F749 - F756.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. Parnot, J.-M. Le Moullec, M.-A. Cousin, D. Guedin, P. Corvol, and F. Pinet
A Live-Cell Assay for Studying Extracellular and Intracellular Endothelin-Converting Enzyme Activity
Hypertension, October 1, 1997; 30(4): 837 - 844.
[Abstract] [Full Text]


Home page
CirculationHome page
T. Minamino, H. Kurihara, M. Takahashi, K. Shimada, K. Maemura, H. Oda, T. Ishikawa, T. Uchiyama, K. Tanzawa, and Y. Yazaki
Endothelin-Converting Enzyme Expression in the Rat Vascular Injury Model and Human Coronary Atherosclerosis
Circulation, January 7, 1997; 95(1): 221 - 230.
[Abstract] [Full Text]


Home page
J. Appl. Physiol.Home page
D. Dunbar Ivy, J. P. Kinsella, and S. H. Abman
Endothelin blockade augments pulmonary vasodilation in the ovine fetus
J Appl Physiol, December 1, 1996; 81(6): 2481 - 2487.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. Pernow, L. Kaijser, J. M. Lundberg, and G. Ahlborg
Comparable Potent Coronary Constrictor Effects of Endothelin-1 and Big Endothelin-1 in Humans
Circulation, November 1, 1996; 94(9): 2077 - 2082.
[Abstract] [Full Text]


Home page
CirculationHome page
F. Brunner and W. R. Kukovetz
Postischemic Antiarrhythmic Effects of Angiotensin-Converting Enzyme Inhibitors: Role of Suppression of Endogenous Endothelin Secretion
Circulation, October 1, 1996; 94(7): 1752 - 1761.
[Abstract] [Full Text]


Home page
J. Cell Sci.Home page
K Barnes, K Shimada, M Takahashi, K Tanzawa, and A. Turner
Metallopeptidase inhibitors induce an up-regulation of endothelin-converting enzyme levels and its redistribution from the plasma membrane to an intracellular compartment
J. Cell Sci., January 5, 1996; 109(5): 919 - 928.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
N. Emoto and M. Yanagisawa
Endothelin-converting Enzyme-2 Is a Membrane-bound, Phosphoramidon-sensitive Metalloprotease with Acidic pH Optimum
J. Biol. Chem., June 23, 1995; 270(25): 15262 - 15268.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1992 by The Federation of American Societies for Experimental Biology.